BioNTech ADR earns the No. 143 rank among its peers in the Medical-Biomed/Biotech industry group. Aurinia Pharmaceuticals ...

The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...

Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization.

The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.

Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly ...

Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...

Showing that his loyalty to his own anti-vax mentality is greater than his loyalty to Donald Trump, Robert F. Kennedy Jr., ...

Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.

In litigation over the past two years, CureVac alleged the BioNTech and Pfizer vaccine for Covid-19 infringed CureVac patents based on its more than two decades of mRNA research. Under terms of the ...

In Germany, the Regional Court found that Pfizer and BioNTech infringed Moderna’s modified mRNA patent and confirmed Moderna’s right to seek damages. An appeal is pending.

BioNTech expects its revenues for the full 2025 financial year to be in the range of €1,700 - €2,200 million and revenue phasing primarily concentrated in the last three to four months ...